The medical technology company Senzime is expanding the use of TetraGraph to monitor electroconvulsive therapy (ECT) for severe psychiatric conditions.
The system monitors the effect of muscle-relaxing drugs and the patient’s recovery. According to the company, 10 million ECT treatments are carried out globally each year, increasing the addressable market by around 10 percent.
